These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

124 related items for PubMed ID: 1376836

  • 1. Clinical efficacy and tolerability of isradipine in the treatment of mild-to-moderate hypertension in young and elderly patients.
    Batlouni M, Armaganijan D, Ghorayeb N, Magliano MF.
    J Cardiovasc Pharmacol; 1992; 19 Suppl 3():S53-7. PubMed ID: 1376836
    [Abstract] [Full Text] [Related]

  • 2. Isradipine in the treatment of mild-to-moderate hypertension in Portugal.
    Pereira-Miguel JM, Correa-Nunes A, Rocha-Gonçalves F, Mariano-Pego G.
    J Cardiovasc Pharmacol; 1992; 19 Suppl 3():S49-52. PubMed ID: 1376835
    [Abstract] [Full Text] [Related]

  • 3. First clinical experience with isradipine in the treatment of hypertension in Portugal.
    Rocha-Gonçalves F, Mariano-Pego G, Viegas J, Correia JM, Botelho MA.
    J Cardiovasc Pharmacol; 1991; 18 Suppl 3():S4-6. PubMed ID: 1720485
    [Abstract] [Full Text] [Related]

  • 4. [A Brazilian multicenter study to evaluate the clinical effectiveness and tolerance of isradipine SRO using ambulatory monitoring of arterial pressure in the treatment of mild and moderate arterial hypertension].
    Magliano MF, Amodeo C, Mion Júnior D, Francischetti E, Lima Júnior E, Nobre F, Chaves H, Ribeiro JM, Spritzer N, Jardim PC.
    Arq Bras Cardiol; 1993 Nov; 61(5):311-8. PubMed ID: 8147731
    [Abstract] [Full Text] [Related]

  • 5. Tolerability of isradipine in the treatment of mild-to-moderate hypertension in general practice: a large-scale surveillance study.
    Hermans L, Bogaert M, Degaute JP, Rorive G, Six R, Bara L, Lanssiers P, De Keyser P, Westelinck KJ.
    J Cardiovasc Pharmacol; 1992 Nov; 19 Suppl 3():S38-45. PubMed ID: 1376833
    [Abstract] [Full Text] [Related]

  • 6. Results of a phase III, 8-week, multicenter, prospective, randomized, double-blind, parallel-group clinical trial to assess the effects of amlodipine camsylate versus amlodipine besylate in Korean adults with mild to moderate hypertension.
    Kim SH, Kim YD, Lim DS, Yoon MH, Ahn YK, On YK, Lee JW, Kim IJ, Park JB, Kim JJ, Chung WS, Yang JY, Seo HS, Shin EK, Kim HS, Korean Multicenter Amlodipine Study Investigators.
    Clin Ther; 2007 Sep; 29(9):1924-36. PubMed ID: 18035192
    [Abstract] [Full Text] [Related]

  • 7. Evaluation of isradipine and captopril alone or in combination for the treatment of hypertension.
    Fitscha P, Meisner W, Hitzenberger G.
    J Cardiovasc Pharmacol; 1991 Sep; 18 Suppl 3():S12-4. PubMed ID: 1720478
    [Abstract] [Full Text] [Related]

  • 8. Metabolic, hematological, and cardiac effects of long-term isradipine treatment in mild-to-moderate essential hypertension.
    Meriç M, Gören T, Atilgan D, Eren N, Cubukçu A, Koylan N.
    J Cardiovasc Pharmacol; 1992 Sep; 19 Suppl 3():S58-60. PubMed ID: 1376837
    [Abstract] [Full Text] [Related]

  • 9. Calcium antagonists as first-line therapy in hypertension: results of the Swiss Isradipine Study. Swiss Hypertension Society.
    Lüscher TF, Waeber B.
    J Cardiovasc Pharmacol; 1991 Sep; 18 Suppl 3():S1-3. PubMed ID: 1720476
    [Abstract] [Full Text] [Related]

  • 10. Efficacy and safety of delapril plus manidipine compared with enalapril plus hydrochlorothiazide in mild to moderate essential hypertension: results of a randomized trial.
    Mugellini A, Dobovisek J, Planinc D, Cremonesi G, Fogari R.
    Clin Ther; 2004 Sep; 26(9):1419-26. PubMed ID: 15531004
    [Abstract] [Full Text] [Related]

  • 11. Clinical studies on isradipine in the management of adult hypertensive patients at Moi University Teaching Hospital, Eldoret, Kenya.
    Lore W, Anjichi GM.
    East Afr Med J; 1992 Feb; 69(2):69-73. PubMed ID: 1387077
    [Abstract] [Full Text] [Related]

  • 12. Clinic blood pressure responses to two amlodipine salt formulations, adipate and besylate, in adult Korean patients with mild to moderate hypertension: a multicenter, randomized, double-blind, parallel-group, 8-week comparison.
    Lee HY, Kang HJ, Koo BK, Oh BH, Heung-Sun K, Kim KS, Seo HS, Ro YM, Kang JH, Woong CJ, Joo SJ, Kim MH, Joon-Han S, Yoon J, Park SH, Jin-Ok J, Ju AK, Chong-Yun R, Yeon KJ, Park KM, Lim DK, Park SY, Amostar Study Investigators.
    Clin Ther; 2005 Jun; 27(6):728-39. PubMed ID: 16117979
    [Abstract] [Full Text] [Related]

  • 13. Efficacy, tolerability and safety of isradipine (Lomir) in the treatment of mild to moderate Tanzanian hypertensives.
    Lwakatare JM, Maro EE, Mtulia IA.
    East Afr Med J; 1992 Dec; 69(12):683-7. PubMed ID: 1298633
    [Abstract] [Full Text] [Related]

  • 14. Efficacy and tolerability of the new calcium antagonist isradipine in essential hypertension.
    Kirch W, Burger KJ, Weidinger G, Welzel D.
    J Cardiovasc Pharmacol; 1990 Dec; 15 Suppl 1():S55-9. PubMed ID: 1695304
    [Abstract] [Full Text] [Related]

  • 15. Efficacy and tolerability of combination therapy with valsartan plus hydrochlorothiazide compared with amlodipine monotherapy in hypertensive patients with other cardiovascular risk factors: the VAST study.
    Ruilope LM, Malacco E, Khder Y, Kandra A, Bönner G, Heintz D.
    Clin Ther; 2005 May; 27(5):578-87. PubMed ID: 15978306
    [Abstract] [Full Text] [Related]

  • 16. Results of a multicenter, 8-week, parallel-group, randomized,double-blind, double-dummy, Phase III clinical trial to evaluate the efficacy and tolerability of amlodipine maleate versus amlodipine besylate in Korean patients with mild to moderate hypertension.
    Park S, Chung N, Kwon J, Yoon JH, Kim YJ, Han DS, Kim HS.
    Clin Ther; 2005 Apr; 27(4):441-50. PubMed ID: 15922817
    [Abstract] [Full Text] [Related]

  • 17. Two multicenter, 8-week, randomized, double-blind, placebo-controlled, parallel-group studies evaluating the efficacy and tolerability of amlodipine and valsartan in combination and as monotherapy in adult patients with mild to moderate essential hypertension.
    Philipp T, Smith TR, Glazer R, Wernsing M, Yen J, Jin J, Schneider H, Pospiech R.
    Clin Ther; 2007 Apr; 29(4):563-80. PubMed ID: 17617280
    [Abstract] [Full Text] [Related]

  • 18. Multicentric, clinical trial of S-Amlodipine 2.5 mg versus Amlodipine 5 mg in the treatment of mild to moderate hypertension--a randomized, double-blind clinical trial.
    Pathak L, Hiremath, Kerkar PG, Manade VG.
    J Assoc Physicians India; 2004 Mar; 52():197-202. PubMed ID: 15636308
    [Abstract] [Full Text] [Related]

  • 19. [Isradipine: a Brazilian multicenter study for the evaluation of the efficacy and safety in the treatment of mild and moderate arterial hypertension].
    Magliano MF, do Couto AA, Drumond Neto C, Cantarelli E, Nobre F, Feitosa G, Rocha JC, Nicolau JC, Ribeiro JM, Spritzer N.
    Arq Bras Cardiol; 1992 Jan; 58(1):63-8. PubMed ID: 1444871
    [Abstract] [Full Text] [Related]

  • 20. An 18-week, prospective, randomized, double-blind, multicenter study of amlodipine/ramipril combination versus amlodipine monotherapy in the treatment of hypertension: the assessment of combination therapy of amlodipine/ramipril (ATAR) study.
    Miranda RD, Mion D, Rocha JC, Kohlmann O, Gomes MA, Saraiva JF, Amodeo C, Filho BL.
    Clin Ther; 2008 Sep; 30(9):1618-28. PubMed ID: 18840367
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.